Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human ATP6V0D2 Anticorps:
anti-Mouse (Murine) ATP6V0D2 Anticorps:
anti-Rat (Rattus) ATP6V0D2 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Arabidopsis thaliana Polyclonal ATP6V0D2 Primary Antibody pour IHC, WB - ABIN3197488
Hinton, Sennoune, Bond, Fang, Reuveni, Sahagian, Jay, Martinez-Zaguilan, Forgac: Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells. dans The Journal of biological chemistry 2009
Show all 10 Pubmed References
Human Monoclonal ATP6V0D2 Primary Antibody pour ELISA, WB - ABIN566966
Teramachi, Zhou, Subler, Kitagawa, Galson, Dempster, Windle, Kurihara, Roodman: Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. dans Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2014
Show all 2 Pubmed References
Cow (Bovine) Polyclonal ATP6V0D2 Primary Antibody pour WB - ABIN2786234
Morel: Neurotransmitter release: the dark side of the vacuolar-H+ATPase. dans Biology of the cell / under the auspices of the European Cell Biology Organization 2003
Show all 3 Pubmed References
Top single-nucleotide polymorphism rs9590614 in VMA8 (Montrer ATP6V1D Anticorps) is located within genes that function in cell-cell signaling and cell migration.
these data suggest that Adrm1 (Montrer Adrm1 Anticorps), a new Atp6v0d2-interacting protein, plays an important role in osteoclast differentiation, and in particular the fusion of preosteoclasts.
High V-ATPase (Montrer ATP6V1H Anticorps) expression is associated with Bone Pain Induced by Multiple Myeloma.
we propose that PTH (Montrer PTH Anticorps) has a direct effect on osteoblasts and osteoclasts, and that this effect is mediated through PTH1R (Montrer PTH1R Anticorps), thus contributing to bone remodeling
Insulin (Montrer INS Anticorps) significantly activated ERK1/2 MAP kinase (Montrer MAPK1 Anticorps) as well as markedly induced the expression of NFATc1 (Montrer NFATC1 Anticorps), an osteoclast marker gene, and Atp6v0d2, an osteoclast fusion-related gene.
V-ATPase (Montrer ATP6V1H Anticorps) has a role in modulating a macrophage phenotype towards tumor-associated macrophages through the action of the a2 isoform of V-ATPase (Montrer ATP6V1H Anticorps)
Luteolin can be effective in reducing bone resorption and that this effect of luteolin may be through disruption of osteoclast V-ATPase a3 (Montrer TCIRG1 Anticorps)-d2 interaction.
PKCdelta (Montrer PKCd Anticorps) deficiency does not perturb formation of the ruffled border or trafficking of lysosomal vesicles containing the vacuolar-ATPase (v-ATPase (Montrer DNAH8 Anticorps)).
these findings suggest that the critical role of ATP6v0d2 may be limited to the control of bone homeostasis under normal development.
The data indicate that integrity of lipid rafts regulates the activity of V-ATPase (Montrer ATP6V1H Anticorps) in osteoclasts, suggesting that cholesterol-lowering agents might be useful for inhibiting osteoclast-dependent bone resorption.
Atp6v0d2 is a regulator of osteoclast fusion and bone formation.
Data indicate for the first time that the NFATc1 (Montrer NFATC1 Anticorps)/Atp6v0d2 and DC-STAMP (Montrer TM7SF4 Anticorps) signaling axis plays a key role in the osteoclast multinucleation process, which is essential for efficient bone resorption.
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c', and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This gene encodes the V1 domain D subunit protein.
ATPase, H+ transporting lysosomal, member M
, ATPase, H+ transporting, lysosomal (vacuolar proton pump)
, H(+)-transporting two-sector ATPase, subunit M
, V-ATPase 28 kDa accessory protein
, V-ATPase D subunit
, V-ATPase subunit D
, V-type proton ATPase subunit D
, vacuolar ATP synthase subunit D
, vacuolar H-ATPase subunit D
, vacuolar proton pump D subunit
, vacuolar proton pump delta polypeptide
, vacuolar proton pump subunit D
, vacuolar proton-ATPase subunit D
, V-ATPase subunit d 2
, V-type proton ATPase subunit d 2
, vacuolar proton pump subunit d 2
, ATPase, H+ transporting, V0 subunit D
, osteoclast-specific vacuolar ATP synthase
, vacuolar proton-translocating ATPase d subunit d2
, ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2
, ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d
, Vacuolar proton pump subunit d 2
, ATPase, H+ transporting, lysosomal V0 subunit D2